Catalent Inc Stock Ownership - Who owns Catalent?

Insider buying vs selling

Have Catalent Inc insiders been buying or selling?
Ricky HopsonPres. Clinical Dev Supply Div2023-01-23643$49.36
Manja BoermanPres. BioModalities Division2022-12-05780$51.70
Michael J. GrippoSVP Strategy Corp. Dev.2022-10-312,451$65.83
Christa KreuzburgDirector2022-10-27421$66.27
Thomas W. HawkeswoodPres. Pharma Prod Delivery Div2022-10-10930$77.46
Ricky HopsonPres. Clinical Dev Supply Div2022-08-312,216$89.59
Scott GuntherSVP Quality & Reg. Affairs2022-08-261,639$104.07
Michael A. RileyPres. Bio Product Delivery Div2022-08-262,491$104.07
Kay A. SchmidtSVP Enterprise Functions2022-08-251,321$103.04
Jonathan ArnoldSVP & Chief Commercial Ofcr2022-08-25384$103.04

1 of 5

CTLT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CTLT insiders and whales buy or sell their stock.

CTLT Shareholders

What type of owners hold Catalent Inc stock?
Blackstone Healthcare Partners LLC22.23%40,030,960$2.59BInsider
Vanguard Group Inc10.88%19,588,103$1.27BInstitution
T Rowe Price Investment Management Inc9.21%16,578,946$1.07BInstitution
Capital World Investors7.67%13,817,203$893.28MInstitution
Blackrock Inc7.66%13,789,156$891.47MInstitution
Veritas Asset Management LLP6.20%11,169,815$722.13MInstitution
Peter Zippelius4.82%8,672,903$560.70MInsider
Janus Henderson Group PLC4.56%8,216,242$531.18MInstitution
Artisan Partners Limited Partnership4.35%7,842,308$507.01MInstitution
State Street Corp4.09%7,367,321$476.30MInstitution

1 of 3

CTLT vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CTLT78.76%21.24%Net SellingNet Selling
VTRS77.35%17.72%Net SellingNet Selling
TEVA50.52%0.80%Net SellingNet Selling
PRGO61.63%38.37%Net BuyingNet Buying

Catalent Stock Ownership FAQ

Who owns Catalent?

Catalent (NYSE: CTLT) is owned by 103.38% institutional shareholders, 27.88% Catalent insiders, and 0.00% retail investors. Blackstone Healthcare Partners LLC is the largest individual Catalent shareholder, owning 40.03M shares representing 22.23% of the company. Blackstone Healthcare Partners LLC's Catalent shares are currently valued at $2.51B.

If you're new to stock investing, here's how to buy Catalent stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.